1 |
Watanabe, N., Matsuda, S., Kuramochi, S., Tsuzuku, J., Yamamoto, T. and Endo, K. (1995) Expression of C-terminal src Kinase in Human Colorectal Cancer Cell Lines. Jpn. J. Clin. Oncol. 25: 5-9.
|
2 |
Bougert, C., Jiang, S., Keydar, I. and Avraham, H. (2001) Functional analysis of Csk and CHK kinases in breast cancer cancer cells. J. Biol. Chem. 276: 33711-33720.
DOI
ScienceOn
|
3 |
Kim, M. H., Jung, M. A., Hwang, Y. S., Jeong, M., Kim, S. M., Ahn, S. J., Shin, B. A., Ahn, B. W. and Jung, Y. D. (2004) Regulation of urokinase plasminogen activator by epigallocatechin-3-gallate in human fibrosarcoma cells. Eur. J Pharmacol. 487: 1-6.
DOI
ScienceOn
|
4 |
Lim, Y. C., Park, H. Y., Hwang, H. S., Kang, S. U., Pyun, J. H., Lee, M. H., Choi, E. C. and Kim, C. H. (2008) (-)-Epigallocatechin-3- gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer. Lett. 271: 140-152.
DOI
ScienceOn
|
5 |
Li, H., Lindenmeyer, F., Grenet, C., Opolon, P., Menashi, S., Soria, C., Yeh, P., Perricaudet, M. and Lu, H. (2001) AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum. Gene. Ther. 12: 515-526
DOI
ScienceOn
|
6 |
Maeda-Yamamoto, M., Kawahara, H., Tahara, N., Tsuji, K., Hara, Y. and Isemura, M. (1999) Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J. Agric. Food. Chem. 47: 2350-2354.
DOI
ScienceOn
|
7 |
Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R. and Albini, A. (2001) Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91: 822-832.
DOI
ScienceOn
|
8 |
Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S. J. and Fujiki, H. (1993) Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23: 186-190.
|
9 |
Samuelsen, B. (2000) The traditional uses, chemical constituents and biological activities of Plantago major L. A review. J. Ethnopharmacol. 71: 1-21.
DOI
ScienceOn
|
10 |
Cowan, M. M. (1999) Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12: 564-582.
|
11 |
Riegsecker, S., Wiczynski, D., Kaplan M. J. and Ahmed, S. (2013) Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 93: 307-312.
DOI
ScienceOn
|
12 |
Gye, M. C., Choi, J. K., Ahn, H. S. and Kim, Y. S. (2004) Expression of p50 C-terminal Src kinase (Csk) in mouse testis. Arch. Androl. 50: 287-93.
DOI
ScienceOn
|
13 |
Duan, L. J., Imamoto, A. and Fong, G. H. (2004) Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization. Blood 103: 1370-1372.
|
14 |
Aki, D., Mashima, R., Saeki, K., Minoda, Y., Yamauchi, M. and Yoshimura, A. (2005) Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages. Genes Cells 10: 357-368.
DOI
ScienceOn
|
15 |
Jankun, J., Selman, S. H., Swiercz, R. and Skrzypezak-Jankun, E. (1997) Why drinking green tea could prevent cancer. Nature 387: 561.
DOI
ScienceOn
|
16 |
Sen B., Johnson F. M. (2011) Regulation of Src Family Kinases in Human Cancers. J. Signal Transduct., 2011: 865819.
|
17 |
Du GJ1, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ. (2012) Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 8: 1679-1691.
|
18 |
Takayama, Y., Nada, S., Nagai, K. and Okada, M. (1997) Role of Csk in neural differentiation of the embryonic carcinoma cell line P19. FEBS Lett. 406: 11-6.
DOI
ScienceOn
|
19 |
Ren, W., Qiao, Z., Wang, H. and Zhang, L. (2003) Flavonoids: Promising anticancer agents. Med. Res. Rev. 23: 519-534.
|
20 |
Kim, H. S., Quon M. J. and Kim, J. A. (2014) New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox. Biol. 2: 187-195.
DOI
ScienceOn
|
21 |
Yiannakopoulou ECh. (2013) Targeting oxidative stress response by green tea polyphenols: clinical implications. Free Radic. Res. 47: 667-671.
DOI
ScienceOn
|
22 |
Di Carlo, G., Mascolo, N., Izzo, A. A. and Capasso, F. (1999) Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci. 65: 337-353.
DOI
ScienceOn
|
23 |
Liang, Y. C., Lin-shiau, S. Y., Chen, C. F. and Lin, J. K. (1997) Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell. Biochem. 67: 55-65.
DOI
ScienceOn
|
24 |
Park, S. Y., Jung, C. H., Song, B., Park, O. J. and Kim, Y. M. (2013) Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression. Oncol Lett. 6: 1346-1350.
DOI
|
25 |
Iriti, M. and Varoni, E. M. (2013) Chemopreventive potential of flavonoids in oral squamouse cell carcinoma in human studies. Nutrients 5: 2564-2576.
DOI
|
26 |
Deb, G., Thakur, V. S., Limaye, A. M. and Gupta, S. (2014) Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol. Carcinog. doi: 10.1002/mc.22121.
|
27 |
Donejko, M., Niczyporuk, M., Galicka, E. and Przylipiak, A. (2013) Anti-cancer properties epigallocatechin-gallate contained in green tea. Postepy Hig. Med. Dosw. (Online) 67: 26-34.
DOI
|
28 |
Liu, J. W., Nagao, N., Kageyama, K. and Miwa, N. (1999) Antimetastatic and antiinvasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action. Oncol. Res. 11: 479-487.
|
29 |
Li, H., Li, Z., Xu, Y. M., Wu, Y., Yu, K. K., Zhang, C., Ji, Y. H., Ding, G. and Chen, F. X. (2014) Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell. Neurosci. Bull. 30: 67-73.
DOI
|
30 |
Zhang, G., Miura, Y. and Yagasaki, K. (2000) Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett. 159: 169-173.
DOI
ScienceOn
|
31 |
Cao, Y. and Cao, R. (1999) Angiogenesis inhibited by drinking tea. Nature. 398: 381.
DOI
ScienceOn
|
32 |
Darweish, M. M., Abbas, A., Ebrahim, M. A. and Al-Gayyar, M. M. (2014) Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. J. Pharm. Pharmacol. doi: 10.1111/jphp.12229.
|
33 |
Dong, Z., Ma, W., Huang, C. and Yang, C. S. (1997) Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer. Res. 57: 4414-4419.
|
34 |
Bruns, C. J., Harbison, M. T., Davis, D. W., Portera, C. A., Tsan, R., McConkey, D. J., Evans, D. B., Abbruzzese, J. L., Hicklin, D. J. and Radinsky, R. (2000) Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin. Cancer. Res. 6: 1936-1948.
|
35 |
Darvesh, A. S. and Bishayee, A. (2013) Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr. Cancer. 65: 329-344.
DOI
ScienceOn
|
36 |
Ho, Y. C., Yang, S. F., Peng, C. Y., Chou, M. Y. and Chang, Y. C. (2007) Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J. Oral. Pathol. Med. 36: 588-593.
DOI
ScienceOn
|